These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 18964022

  • 21. Why and how to monitor the cost and evaluate the cost-effectiveness of HIV services in countries.
    Beck EJ, Santas XM, Delay PR.
    AIDS; 2008 Jul; 22 Suppl 1():S75-85. PubMed ID: 18664958
    [Abstract] [Full Text] [Related]

  • 22. Examining the production costs of antiretroviral drugs.
    Pinheiro E, Vasan A, Kim JY, Lee E, Guimier JM, Perriens J.
    AIDS; 2006 Aug 22; 20(13):1745-52. PubMed ID: 16931939
    [Abstract] [Full Text] [Related]

  • 23. [Access to treatment of HIV/AIDS in the South: the challenges of sustainability].
    Kazatchkine M, Moatti JP.
    Med Sci (Paris); 2008 Dec 22; 24(12):1007-8. PubMed ID: 19116101
    [No Abstract] [Full Text] [Related]

  • 24. Soaring antiretroviral prices, TRIPS and TRIPS flexibilities: a burning issue for antiretroviral treatment scale-up in developing countries.
    Orsi F, d'almeida C.
    Curr Opin HIV AIDS; 2010 May 22; 5(3):237-41. PubMed ID: 20539080
    [Abstract] [Full Text] [Related]

  • 25. Drugs for the developing world.
    GMHC Treat Issues; 2010 May 22; 12(1):32. PubMed ID: 11364989
    [Abstract] [Full Text] [Related]

  • 26. An unequal activism for an unequal epidemic?
    Selemogo M.
    Dev World Bioeth; 2005 May 22; 5(2):153-68. PubMed ID: 15842724
    [Abstract] [Full Text] [Related]

  • 27. 'Time is costly': modelling the macroeconomic impact of scaling-up antiretroviral treatment in sub-Saharan Africa.
    Ventelou B, Moatti JP, Videau Y, Kazatchkine M.
    AIDS; 2008 Jan 02; 22(1):107-13. PubMed ID: 18090398
    [Abstract] [Full Text] [Related]

  • 28. Perspectives on the pediatric HIV/AIDS pandemic: catalyzing access of children to care and treatment.
    Kline MW.
    Pediatrics; 2006 Apr 02; 117(4):1388-93. PubMed ID: 16585337
    [Abstract] [Full Text] [Related]

  • 29. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.
    Orsi F, D'Almeida C, Hasenclever L, Camara M, Tigre P, Coriat B.
    AIDS; 2007 Oct 01; 21(15):1997-2003. PubMed ID: 17885289
    [No Abstract] [Full Text] [Related]

  • 30. The human right to health, national courts, and access to HIV/AIDS treatment: a case study from Venezuela.
    Torres MA.
    Chic J Int Law; 2002 Oct 01; 3(1):105-14. PubMed ID: 15709302
    [No Abstract] [Full Text] [Related]

  • 31. Different delivery models for antiretroviral therapy in sub-Saharan Africa in the context of 'universal access'.
    Harries AD, Makombe SD, Schouten EJ, Ben-Smith A, Jahn A.
    Trans R Soc Trop Med Hyg; 2008 Apr 01; 102(4):310-1. PubMed ID: 18316103
    [Abstract] [Full Text] [Related]

  • 32. Access to antiretroviral treatment in developing countries: Which financing strategies are possible?
    Beaulière A, Le Maux A, Trehin C, Perez F.
    Rev Epidemiol Sante Publique; 2010 Jun 01; 58(3):171-9. PubMed ID: 20430553
    [Abstract] [Full Text] [Related]

  • 33. Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up.
    Calmy A, Klement E, Teck R, Berman D, Pécoul B, Ferradini L.
    AIDS; 2004 Dec 03; 18(18):2353-60. PubMed ID: 15622311
    [No Abstract] [Full Text] [Related]

  • 34. Comment on Ford et al., 'Sustaining access to antiretroviral therapy in developing countries: lessons from Brazil and Thailand'.
    Stewart JR.
    AIDS; 2007 Jul 03; 21 Suppl 4():S129; author reply S129-30. PubMed ID: 17620760
    [No Abstract] [Full Text] [Related]

  • 35. Are country reputations for good and bad leadership on AIDS deserved? An exploratory quantitative analysis.
    Nattrass N.
    J Public Health (Oxf); 2008 Dec 03; 30(4):398-406. PubMed ID: 18791202
    [Abstract] [Full Text] [Related]

  • 36. Sustaining treatment costs: who will pay?
    Zewdie D, De Cock K, Piot P.
    AIDS; 2007 Jul 03; 21 Suppl 4():S1-4. PubMed ID: 17620744
    [No Abstract] [Full Text] [Related]

  • 37. Challenge and co-operation: civil society activism for access to HIV treatment in Thailand.
    Ford N, Wilson D, Cawthorne P, Kumphitak A, Kasi-Sedapan S, Kaetkaew S, Teemanka S, Donmon B, Preuanbuapan C.
    Trop Med Int Health; 2009 Mar 03; 14(3):258-66. PubMed ID: 19207173
    [Abstract] [Full Text] [Related]

  • 38. Inequalities in health: access to treatment for HIV/AIDS.
    Giuliano M, Vella S.
    Ann Ist Super Sanita; 2007 Mar 03; 43(4):313-6. PubMed ID: 18209264
    [Abstract] [Full Text] [Related]

  • 39. A visit to India: drug prices, research, & global access.
    Scondras D.
    AIDS Treat News; 1999 Jan 22; (No 311):6-8. PubMed ID: 11366155
    [Abstract] [Full Text] [Related]

  • 40. Simplifying HIV therapeutics, and the global treatment of AIDS.
    Laurence J.
    AIDS Read; 2003 Jan 22; 13(1):5-6. PubMed ID: 12569889
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.